MetrioPharm is a clinical-stage company that develops safe and effective treatments based on first-in-class self-regulating immunomodulators for inflammatory and infectious diseases. The company's lead candidate MP1032 is an oral small molecule immune modulator targeting dysregulated mitochondrial metabolism in immune cells, aimed at reducing the side effects of corticosteroid ...Show More
peer of
Metrics
marketPRIVATE
msh_idCOM:METRIOPHARM
localede
websitehttps://metriopharm.com
source_ref194e5746-0774-4d9d-8e92-e6560bef4b8f
products_or_servicesDevelopment of self-regulating immunomodulators for inflammatory and infectious diseases, particularly MP1032 for various indications.
Germany